MedPath

Praziquantel

Generic Name
Praziquantel
Brand Names
Biltricide
Drug Type
Small Molecule
Chemical Formula
C19H24N2O2
CAS Number
55268-74-1
Unique Ingredient Identifier
6490C9U457
Background

An anthelmintic used in most schistosome and many cestode infestations.

Indication

For the treatment of infections due to all species of schistosoma.

Associated Conditions
Cestode infections, Cysticercosis, Liver fluke infection, Trematode infections, Schistosoma infection

Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children

Not Applicable
Conditions
Seasonal Malaria Chemoprevention
Mass Drug Administration With Anthelminthic Drugs
Soil Transmitted Helminths
Schistosomiasis
Malaria
Integrated Control
Interventions
First Posted Date
2022-04-29
Last Posted Date
2022-07-14
Lead Sponsor
London School of Hygiene and Tropical Medicine
Target Recruit Count
600
Registration Number
NCT05354258
Locations
🇸🇳

Saraya Health Centre, Saraya, Kedougou, Senegal

Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni

Phase 2
Completed
Conditions
Schistosoma Mansoni
Interventions
Dietary Supplement: Ujiplus®
First Posted Date
2020-12-22
Last Posted Date
2022-07-12
Lead Sponsor
Kenya Medical Research Institute
Target Recruit Count
400
Registration Number
NCT04679831
Locations
🇰🇪

Mbita, Mbita, Kenya

Monitoring Schistosome Hybrids Under Under Praziquantel Pressure

Conditions
Schistosomiasis
First Posted Date
2020-11-19
Last Posted Date
2020-11-19
Lead Sponsor
Institut de Recherche pour le Developpement
Target Recruit Count
250
Registration Number
NCT04635553
Locations
🇸🇳

Bruno SENGHOR, Dakar, Senegal

Bioequivalence Study of Coated Cesol Tablet Formulation Versus Biltricide

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2020-03-18
Last Posted Date
2021-08-13
Lead Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Target Recruit Count
36
Registration Number
NCT04314037
Locations
🇩🇪

Nuvisan GmbH, Neu-Ulm, Germany

Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study

Phase 2
Completed
Conditions
Schistosomiasis
Interventions
First Posted Date
2019-10-03
Last Posted Date
2020-05-18
Lead Sponsor
Vendsyssel Hospital
Target Recruit Count
116
Registration Number
NCT04115072
Locations
🇲🇬

K'Olo Vanona, Ambanja, Diana, Madagascar

Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children

Phase 3
Completed
Conditions
Schistosoma Haematobium
Schistosoma Mansoni
Interventions
First Posted Date
2019-03-28
Last Posted Date
2021-04-05
Lead Sponsor
Institute of Tropical Medicine, Belgium
Target Recruit Count
726
Registration Number
NCT03893097
Locations
🇸🇳

Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF), Dakar, Senegal

L-PZQ ODT in Schistosoma Infected Children

Phase 3
Completed
Conditions
Schistosomiasis
Interventions
First Posted Date
2019-02-19
Last Posted Date
2024-03-21
Lead Sponsor
Merck KGaA, Darmstadt, Germany
Target Recruit Count
288
Registration Number
NCT03845140
Locations
🇰🇪

Kemri Kisumu, Kisumu, Kenya

🇨🇮

Universitè de Cocody, Abidjan, Côte D'Ivoire

Schistosomiasis Diagnosis Using a CAA Antigen Test

Phase 3
Conditions
Schistosomiasis Hematobium
Diagnostic
Drug Reaction
Pregnancy
Interventions
Diagnostic Test: UCP-LF CAA
Diagnostic Test: composite diagnostic
First Posted Date
2018-12-19
Last Posted Date
2021-07-27
Lead Sponsor
Centre de Recherche Médicale de Lambaréné
Target Recruit Count
100
Registration Number
NCT03779347
Locations
🇬🇦

Centre de Recherches Médicales de Lambaréné, Lambaréné, Moyen Ogooué, Gabon

🇬🇦

Centre de Recherches Medicales de Lambaréné, Lambaréné, Gabon

Praziquantel in Children Under Age 4

Phase 2
Conditions
Schistosomiasis
Schistosomiasis Mansoni
Schistosoma Japonicum Infection
Interventions
First Posted Date
2018-08-21
Last Posted Date
2022-05-20
Lead Sponsor
Rhode Island Hospital
Target Recruit Count
600
Registration Number
NCT03640377
Locations
🇬🇧

London School of Tropical Hygiene and Medicine, London, United Kingdom

🇺🇬

Medical Research Council, Entebbe, Uganda

Praziquantel Bioequivalence Study

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Cisticid
First Posted Date
2018-02-19
Last Posted Date
2019-09-18
Lead Sponsor
Merck KGaA, Darmstadt, Germany
Target Recruit Count
60
Registration Number
NCT03437447
Locations
🇲🇽

Clínica de Enfermedades Crónicas y de Procedimientos Especiales, Sociedad Civil (SC), México, Mexico

© Copyright 2025. All Rights Reserved by MedPath